FDA on v erge of approving 3rd vaccine dose for immunocompromised people--report

FDA poised to OK third vaccine dose for immunocompromised people The move would be the first authorization of an additional dose in the U.S. NBC News

The Food and Drug Administration is poised to amend the emergency use authorizations for the Pfizer and the Moderna Covid-19 vaccines Thursday to allow people with compromised immune systems to get a third dose, according to two sources familiar with the plans.

The move would come after a panel of advisers to the Centers for Disease Control and Prevention met in Julyand urged action on extra doses for immunocompromised adults.

Doctors say it is increasingly clear that many such patients are still vulnerable to Covid following vaccination because they may not mount an effective immune response to the shots.

An estimated 2.7 percent of adults in the United States are immunocompromised, according to the CDC. It is unclear which groups would be covered under the expected FDA action. Immunocompromised patients include organ transplant recipients, people undergoing cancer treatment and people with HIV, among others. ...